TransEnterix to Present at the Raymond James Life Sciences and MedTech Conference
06 Junio 2019 - 5:55AM
Business Wire
TransEnterix, Inc. (NYSE American:TRXC) announced today that
Joseph P. Slattery, Executive Vice President and Chief Financial
Officer, will present at the Raymond James Life Sciences and
Medtech Conference at The Lotte New York Palace in New York City.
The presentation is scheduled to take place at 9:10 AM Eastern,
Wednesday, June 19, 2019.
About TransEnterix
TransEnterix is a medical device company that is digitizing the
interface between the surgeon and the patient to improve minimally
invasive surgery by addressing the clinical and economic challenges
associated with current laparoscopic and robotic options in today's
value-based healthcare environment. The Company is focused on the
commercialization of the Senhance Surgical System, which digitizes
laparoscopic minimally invasive surgery. The system allows for
robotic precision, haptic feedback, surgeon camera control via eye
sensing and improved ergonomics while offering responsible
economics. The Senhance Surgical System is available for sale in
the US, the EU, Japan and select other countries. For more
information, visit www.transenterix.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190606005046/en/
TransEnterix, Inc.Investor Contact:Mark Klausner,
443-213-0501transenterix@westwicke.comorMedia Contact:Joanna
Rice, 951-751-1858joanna@greymattermarketing.com
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about TransEnterix Inc New (American Stock Exchange): 0 recent articles
Más de Transenterix, Inc. Artículos de Noticias